Sentinel Lymph Node Biopsy Provides no Benefit for Stage Zero Breast Cancer, Yale School of Public Health Study Finds
Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS), gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found.
HEALTH NOTES: Black and Hispanic Cancer Patients Are Underrepresented in Clinical Trials
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.
Teen Remembers Late Mom as She Prepares for This Year's Closer to Free Ride
When 15-year-old, Elena Hogan-Perez starts pedaling in this year’s Closer To Free Ride, there will be one thing on her mind. “I’ll definitely be thinking about my mother this whole ride, I’ve always thought about her,” she said.
Improving Breast Cancer Outcomes for African Women
For eight days in early June, Melissa Durand, MD, volunteered at the second-largest teaching hospital in Ghana, West Africa. Decades earlier, mammography technologist Judith Abaidoo of Yale New Haven Hospital’s Shoreline Medical Center became one of the first women to perform mammograms in Ghana, where the five-year breast cancer survival rate is estimated to be only 25%.
Expanded insurance coverage for breast cancer screenings lauded by officials, advocates
Harrowing tales from breast cancer survivors from across the state and a slip-up from a freshman legislator are among the circumstances that led to the passage of a bill expanding health care coverage for annual breast cancer screenings.
More women in U.S. receive 3-D mammography but disparities remain
Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale Cancer Center researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
8 Ways to Be There for Yourself After a Breast Cancer Diagnosis
Although learning to cope after a breast cancer diagnosis is a really individual process, experts and survivors we spoke with emphasized that there are a few ways you might be able to make the experience even a little bit easier. Here are their suggestions.
Yale Study Identifies How Cancer Drug Inhibits DNA Repair in Cancer Cells
Yale Cancer Center researchers have found that a cancer drug thought to be of limited use possesses an unforeseen property. It is able to stop certain cancer cells from repairing their DNA in order to survive. The study suggests that combining this drug, cediranib, with other agents could potentially deliver a lethal blow in cancer that uses a specific process to create DNA repair cells.